Bioinformatics Harvard Tempts Quackenbush Away from TIGR | GenomeWeb

After eight years at The Institute for Genomic Research, John Quackenbush moved last month to take a dual appointment at the Harvard School of Public Health and the Dana-Farber Cancer Institute in Cambridge. “I’d been looking around to see how I could grow my research,” Quackenbush says, “and [Harvard] had an attractive offer. They have capacities there in bioinformatics, animal models, cancer, human disease — the opportunities there are outstanding.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.